Eam Global Investors LLC Reata Pharmaceuticals Inc Transaction History

Eam Global Investors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$126.3 - $176.56 $653,855 - $914,051	-5,177 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$124.16 - $247.74 $80,952 - $161,526	652 Added 14.41%	5,177 $747,000
Q4 2019 Feb 10, 2020	SELL	$74.57 - $217.92 $544,510 - $1.59 Million	-7,302 Reduced 61.74%	4,525 $925,000
Q3 2019 Nov 13, 2019	SELL	$71.26 - $95.75 $714,737 - $960,372	-10,030 Reduced 45.89%	11,827 $950,000
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $403,988 - $490,431	-5,198 Reduced 19.21%	21,857 $2.06 Million
Q1 2019 May 10, 2019	BUY	$51.9 - $101.79 $181,027 - $355,043	3,488 Added 14.8%	27,055 $2.31 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $76.44 $192,797 - $302,243	-3,954 Reduced 14.37%	23,567 $1.32 Million
Q3 2018 Nov 08, 2018	BUY	$35.64 - $92.06 $980,848 - $2.53 Million	27,521 New	27,521 $2.25 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.